Effectiveness of an amlodipine and perindopril arginine-based strategy for hypertension management in Morocco: a prospective observational study
Open Access
- 24 December 2025
- journal article
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 52
Abstract
Introduction: hypertension is a leading cause of cardiovascular disease and mortality in Morocco, with many patients remaining uncontrolled on monotherapy. This study evaluated the effectiveness and safety of adding perindopril arginine to amlodipine for better blood pressure (BP) control among patients with hypertension in Morocco. Methods: this multicentre, prospective observational study enrolled 1,614 patients with hypertension who were previously uncontrolled on amlodipine monotherapy and were prescribed perindopril. Baseline characteristics, BP measurements, and adverse events were monitored over 90 days. Results: participants had a mean age of 63.1 ± 11.2 years, with 66.5% being women. Significant BP reductions were observed from baseline to day 90: mean systolic BP decreased from 171.3 mmHg to 128.7 mmHg (mean difference: -42.6 mmHg, p<0.0001) and mean diastolic BP from 92.4 mmHg to 74.6 mmHg (mean difference: -17.8 mmHg, p<0.0001). BP control (<140/90 mmHg) increased from 60.0% of patients at day 30 to 91.3% at day 90 (p<0.0001). Safety assessments indicated minimal adverse events, with incidence decreasing over the study period. By day 90, only 0.25% of participants reported adverse events, including hypotension (0.06%), fatigue (0.06%), and headaches (0.06%). No serious adverse events were reported. Conclusion: Moroccan patients with hypertension treated with a combination of amlodipine and perindopril arginine showed a significant improvement in BP control and a favourable safety profile. This strategy presents a promising approach for managing hypertension in similar populations.Keywords
Funding Information
- This work was supported by Servier, Suresnes, France. Servier had no role in this manuscript's intellectual content and writing.
This publication has 34 references indexed in Scilit:
- Exploring the association of adverse drug reactions with medication adherence and quality of life among hypertensive patients: a cross-sectional studyInternational Journal of Clinical Pharmacy, 2024
- Legacy benefits of blood pressure treatment on cardiovascular events are primarily mediated by improved blood pressure variability: the ASCOT trialEuropean Heart Journal, 2024
- Evaluation of the Safety and Efficacy of Dual Therapy Perindopril/Amlodipine in the Management of Hypertension. A Systematic Review and Meta-AnalysisHigh Blood Pressure & Cardiovascular Prevention, 2022
- Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-AnalysisHigh Blood Pressure & Cardiovascular Prevention, 2020
- Effectiveness of a Fixed-Dose, Single-Pill Combination of Perindopril and Amlodipine in Patients with Hypertension: A Non-Interventional StudyAdvances in Therapy, 2018
- Modifications in drug adherence after switch to fixed-dose combination of perindopril/amlodipine in clinical practice. Results of a large-scale Italian experience. The amlodipine-perindopril in real settings (AMPERES) studyCurrent Medical Research and Opinion, 2018
- Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysisThe Lancet, 2016
- Efficacy and safety of perindopril arginine + amlodipine in hypertensionJournal of the American Society of Hypertension, 2015
- Fixed-Dose Combinations Improve Medication Compliance: A Meta-AnalysisThe American Journal of Medicine, 2007
- Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialThe Lancet, 2005